Drugmakers Plan Price Hikes on 350+ Medicines in 2026 Amidst Government Pressure

Upcoming Drug Price Increases

• 📈 Drugmakers are planning to raise US prices on at least 350 branded medications in 2026, including vaccines for COVID, RSV, and shingles.
• ⚠️ These planned hikes come despite pressure from the Trump administration for drug price cuts.
• 📊 The number of price increases is higher than at the same point last year, though the median price hike of 4% is consistent with 2025.
• 🏷️ These increases do not account for rebates to pharmacy benefit managers or other discounts.

Drug Price Reductions and Government Negotiation

• 📉 Drugmakers also plan to reduce list prices on approximately nine drugs, including the diabetes treatment Jardian ants.
• 🤝 Jardian ants is among the 10 drugs for which the US government has negotiated a lower price for the Medicare program for individuals aged 65 and older in 2026.
• 🤏 A health policy researcher suggests these government negotiation deals are minor and do not address the core drivers of high prescription drug prices in the US.

Global Price Disparities and Pfizer's Adjustments

• 🌎 US patients currently pay significantly more for prescription medicines, often nearly three times the cost compared to other developed nations.
• 💉 Pfizer announced list price hikes on about 80 drugs, including its cancer drug IB brands and COVID vaccine (increasing by 15%).
• 📉 Pfizer stated it adjusted the average list price of its innovative medicines and vaccines for 2026 to be below the overall rate of inflation.
• 🗓️ Further price hikes and cuts are anticipated in early January, which is traditionally the busiest month for drugmakers to implement price changes.